Citi Pharma Limited (PSX:CPHL)
Pakistan flag Pakistan · Delayed Price · Currency is PKR
61.79
-1.28 (-2.03%)
At close: Nov 6, 2026

Citi Pharma Cash Flow Statement

Millions PKR. Fiscal year is Jul - Jun.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Income
835.44790.33892.04833.46657.98653.69
Depreciation & Amortization
222.23206.04168.09138.2290.5976.83
Loss (Gain) From Sale of Investments
-0.3-0.232.79-29.2835.124.48
Provision & Write-off of Bad Debts
11.2611.262.24.78--
Other Operating Activities
170.27-15.71-79.1955.33-26.27136.33
Change in Accounts Receivable
-539.78-403.27-885.74-282.69-480.58-957.02
Change in Inventory
521.25215.95-726.33-594.39-917.35-913.44
Change in Accounts Payable
-410.18-406.96227.321,359260.08782.19
Change in Other Net Operating Assets
-32.95-235.3578.13-146.7951.42-106.03
Operating Cash Flow
777.23162.06-320.71,338-329-322.97
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Capital Expenditures
-804.66-706.69-150.06-568.2-954.47-600.46
Investment in Securities
-0.1863.3442.3152.83179.77-312.12
Other Investing Activities
---5.233.43-6.13-8.91
Investing Cash Flow
-804.84-643.34-112.98-511.94-780.83-921.48

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Short-Term Debt Issued
-6.381,470-1,246509.37
Long-Term Debt Issued
-113.66---300
Total Debt Issued
120.05120.051,470-1,246809.37
Short-Term Debt Repaid
--5.69-37.73-331.54--
Long-Term Debt Repaid
--32.18-45.15-56.17-383.24-148.3
Lease Payments
-34.23-32.18-32.29---
Total Debt Repaid
67.67-37.87-82.89-387.7-383.24-148.3
Net Debt Issued (Repaid)
187.7182.181,387-387.7863.24661.07
Common Dividends Paid
-800.24-800.24-739.82-571.15--311.54
Other Financing Activities
---0.58---521.38
Financing Cash Flow
-612.53-718.06646.82-958.86863.24-171.85

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Miscellaneous Cash Flow Adjustments
-0-0----
Net Cash Flow
-640.14-1,199213.14-133.2-246.58-1,416

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Free Cash Flow
-27.43-544.63-470.77769.4-1,283-923.43
Free Cash Flow Growth
------
Free Cash Flow Margin
-0.19%-3.87%-3.58%6.20%-10.35%-9.44%
Free Cash Flow Per Share
-0.12-2.38-2.063.37-5.62-4.07
Levered Free Cash Flow
66.85-437.2-567.3446.95-1,324-1,497
Unlevered Free Cash Flow
288.13-203.09-368.76631.59-1,240-1,461
Free Cash Flow After Leases
-61.65-576.81-503.06769.4-1,283-923.43

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash Interest Paid
393.4393.4356.83289.99329.358.73
Cash Income Tax Paid
624.71624.71574461.13367.92309.61
Change in Working Capital
-461.66-829.64-1,307335.09-1,086-1,194